Oncology Market Report

Global Oncology Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 02, 2022
  • PAGES：224
  • REPORT CODE：GMM792488
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Oncology market report explains the definition, types, applications, major countries, and major players of the Oncology market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Cepheid

    • Beckton Dickinson

    • Roche Diagnostics

    • Abbott Laboratories

    • Siemens Healthineers

    • Gen Probe

    • Danaher Corporation

    • Sysmex Corporation

    • Qiagen

    • Dako

    • Bayer Healthcare

    By Type:

    • Instruments

    • Reagents

    By End-User:

    • Breast Cancer

    • Prostate Cancer

    • Colorectal Cancer

    • Cervical Cancer

    • Liver Cancer

    • Lung Cancer

    • Blood Cancer

    • Kidney Cancer

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Oncology Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Oncology Outlook to 2028- Original Forecasts

    • 2.2 Oncology Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Oncology Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Oncology Market- Recent Developments

    • 6.1 Oncology Market News and Developments

    • 6.2 Oncology Market Deals Landscape

    7 Oncology Raw Materials and Cost Structure Analysis

    • 7.1 Oncology Key Raw Materials

    • 7.2 Oncology Price Trend of Key Raw Materials

    • 7.3 Oncology Key Suppliers of Raw Materials

    • 7.4 Oncology Market Concentration Rate of Raw Materials

    • 7.5 Oncology Cost Structure Analysis

      • 7.5.1 Oncology Raw Materials Analysis

      • 7.5.2 Oncology Labor Cost Analysis

      • 7.5.3 Oncology Manufacturing Expenses Analysis

    8 Global Oncology Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Oncology Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Oncology Export by Region (Top 10 Countries) (2017-2028)

    9 Global Oncology Market Outlook by Types and Applications to 2022

    • 9.1 Global Oncology Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Instruments Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Reagents Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oncology Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cervical Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Liver Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Blood Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global Kidney Cancer Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Oncology Market Analysis and Outlook till 2022

    • 10.1 Global Oncology Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Oncology Consumption (2017-2022)

      • 10.2.2 Canada Oncology Consumption (2017-2022)

      • 10.2.3 Mexico Oncology Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Oncology Consumption (2017-2022)

      • 10.3.2 UK Oncology Consumption (2017-2022)

      • 10.3.3 Spain Oncology Consumption (2017-2022)

      • 10.3.4 Belgium Oncology Consumption (2017-2022)

      • 10.3.5 France Oncology Consumption (2017-2022)

      • 10.3.6 Italy Oncology Consumption (2017-2022)

      • 10.3.7 Denmark Oncology Consumption (2017-2022)

      • 10.3.8 Finland Oncology Consumption (2017-2022)

      • 10.3.9 Norway Oncology Consumption (2017-2022)

      • 10.3.10 Sweden Oncology Consumption (2017-2022)

      • 10.3.11 Poland Oncology Consumption (2017-2022)

      • 10.3.12 Russia Oncology Consumption (2017-2022)

      • 10.3.13 Turkey Oncology Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Oncology Consumption (2017-2022)

      • 10.4.2 Japan Oncology Consumption (2017-2022)

      • 10.4.3 India Oncology Consumption (2017-2022)

      • 10.4.4 South Korea Oncology Consumption (2017-2022)

      • 10.4.5 Pakistan Oncology Consumption (2017-2022)

      • 10.4.6 Bangladesh Oncology Consumption (2017-2022)

      • 10.4.7 Indonesia Oncology Consumption (2017-2022)

      • 10.4.8 Thailand Oncology Consumption (2017-2022)

      • 10.4.9 Singapore Oncology Consumption (2017-2022)

      • 10.4.10 Malaysia Oncology Consumption (2017-2022)

      • 10.4.11 Philippines Oncology Consumption (2017-2022)

      • 10.4.12 Vietnam Oncology Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Oncology Consumption (2017-2022)

      • 10.5.2 Colombia Oncology Consumption (2017-2022)

      • 10.5.3 Chile Oncology Consumption (2017-2022)

      • 10.5.4 Argentina Oncology Consumption (2017-2022)

      • 10.5.5 Venezuela Oncology Consumption (2017-2022)

      • 10.5.6 Peru Oncology Consumption (2017-2022)

      • 10.5.7 Puerto Rico Oncology Consumption (2017-2022)

      • 10.5.8 Ecuador Oncology Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Oncology Consumption (2017-2022)

      • 10.6.2 Kuwait Oncology Consumption (2017-2022)

      • 10.6.3 Oman Oncology Consumption (2017-2022)

      • 10.6.4 Qatar Oncology Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Oncology Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Oncology Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Oncology Consumption (2017-2022)

      • 10.7.2 South Africa Oncology Consumption (2017-2022)

      • 10.7.3 Egypt Oncology Consumption (2017-2022)

      • 10.7.4 Algeria Oncology Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Oncology Consumption (2017-2022)

      • 10.8.2 New Zealand Oncology Consumption (2017-2022)

    11 Global Oncology Competitive Analysis

    • 11.1 Cepheid

      • 11.1.1 Cepheid Company Details

      • 11.1.2 Cepheid Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Cepheid Oncology Main Business and Markets Served

      • 11.1.4 Cepheid Oncology Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Beckton Dickinson

      • 11.2.1 Beckton Dickinson Company Details

      • 11.2.2 Beckton Dickinson Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Beckton Dickinson Oncology Main Business and Markets Served

      • 11.2.4 Beckton Dickinson Oncology Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Roche Diagnostics

      • 11.3.1 Roche Diagnostics Company Details

      • 11.3.2 Roche Diagnostics Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Roche Diagnostics Oncology Main Business and Markets Served

      • 11.3.4 Roche Diagnostics Oncology Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Abbott Laboratories

      • 11.4.1 Abbott Laboratories Company Details

      • 11.4.2 Abbott Laboratories Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Abbott Laboratories Oncology Main Business and Markets Served

      • 11.4.4 Abbott Laboratories Oncology Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Siemens Healthineers

      • 11.5.1 Siemens Healthineers Company Details

      • 11.5.2 Siemens Healthineers Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Siemens Healthineers Oncology Main Business and Markets Served

      • 11.5.4 Siemens Healthineers Oncology Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Gen Probe

      • 11.6.1 Gen Probe Company Details

      • 11.6.2 Gen Probe Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Gen Probe Oncology Main Business and Markets Served

      • 11.6.4 Gen Probe Oncology Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Danaher Corporation

      • 11.7.1 Danaher Corporation Company Details

      • 11.7.2 Danaher Corporation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Danaher Corporation Oncology Main Business and Markets Served

      • 11.7.4 Danaher Corporation Oncology Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Sysmex Corporation

      • 11.8.1 Sysmex Corporation Company Details

      • 11.8.2 Sysmex Corporation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Sysmex Corporation Oncology Main Business and Markets Served

      • 11.8.4 Sysmex Corporation Oncology Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Qiagen

      • 11.9.1 Qiagen Company Details

      • 11.9.2 Qiagen Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Qiagen Oncology Main Business and Markets Served

      • 11.9.4 Qiagen Oncology Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Dako

      • 11.10.1 Dako Company Details

      • 11.10.2 Dako Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Dako Oncology Main Business and Markets Served

      • 11.10.4 Dako Oncology Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Bayer Healthcare

      • 11.11.1 Bayer Healthcare Company Details

      • 11.11.2 Bayer Healthcare Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Bayer Healthcare Oncology Main Business and Markets Served

      • 11.11.4 Bayer Healthcare Oncology Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Oncology Market Outlook by Types and Applications to 2028

    • 12.1 Global Oncology Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Instruments Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Reagents Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Oncology Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.8 Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Oncology Market Analysis and Outlook to 2028

    • 13.1 Global Oncology Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Oncology Consumption Forecast (2022-2028)

      • 13.2.2 Canada Oncology Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Oncology Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Oncology Consumption Forecast (2022-2028)

      • 13.3.2 UK Oncology Consumption Forecast (2022-2028)

      • 13.3.3 Spain Oncology Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Oncology Consumption Forecast (2022-2028)

      • 13.3.5 France Oncology Consumption Forecast (2022-2028)

      • 13.3.6 Italy Oncology Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Oncology Consumption Forecast (2022-2028)

      • 13.3.8 Finland Oncology Consumption Forecast (2022-2028)

      • 13.3.9 Norway Oncology Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Oncology Consumption Forecast (2022-2028)

      • 13.3.11 Poland Oncology Consumption Forecast (2022-2028)

      • 13.3.12 Russia Oncology Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Oncology Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Oncology Consumption Forecast (2022-2028)

      • 13.4.2 Japan Oncology Consumption Forecast (2022-2028)

      • 13.4.3 India Oncology Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Oncology Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Oncology Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Oncology Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Oncology Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Oncology Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Oncology Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Oncology Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Oncology Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Oncology Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Oncology Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Oncology Consumption Forecast (2022-2028)

      • 13.5.3 Chile Oncology Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Oncology Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Oncology Consumption Forecast (2022-2028)

      • 13.5.6 Peru Oncology Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Oncology Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Oncology Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Oncology Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Oncology Consumption Forecast (2022-2028)

      • 13.6.3 Oman Oncology Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Oncology Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Oncology Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Oncology Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Oncology Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Oncology Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Oncology Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Oncology Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Oncology Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Oncology Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Oncology

    • Figure of Oncology Picture

    • Table Global Oncology Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Oncology Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Instruments Consumption and Growth Rate (2017-2022)

    • Figure Global Reagents Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Liver Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption by Country (2017-2022)

    • Table North America Oncology Consumption by Country (2017-2022)

    • Figure United States Oncology Consumption and Growth Rate (2017-2022)

    • Figure Canada Oncology Consumption and Growth Rate (2017-2022)

    • Figure Mexico Oncology Consumption and Growth Rate (2017-2022)

    • Table Europe Oncology Consumption by Country (2017-2022)

    • Figure Germany Oncology Consumption and Growth Rate (2017-2022)

    • Figure UK Oncology Consumption and Growth Rate (2017-2022)

    • Figure Spain Oncology Consumption and Growth Rate (2017-2022)

    • Figure Belgium Oncology Consumption and Growth Rate (2017-2022)

    • Figure France Oncology Consumption and Growth Rate (2017-2022)

    • Figure Italy Oncology Consumption and Growth Rate (2017-2022)

    • Figure Denmark Oncology Consumption and Growth Rate (2017-2022)

    • Figure Finland Oncology Consumption and Growth Rate (2017-2022)

    • Figure Norway Oncology Consumption and Growth Rate (2017-2022)

    • Figure Sweden Oncology Consumption and Growth Rate (2017-2022)

    • Figure Poland Oncology Consumption and Growth Rate (2017-2022)

    • Figure Russia Oncology Consumption and Growth Rate (2017-2022)

    • Figure Turkey Oncology Consumption and Growth Rate (2017-2022)

    • Table APAC Oncology Consumption by Country (2017-2022)

    • Figure China Oncology Consumption and Growth Rate (2017-2022)

    • Figure Japan Oncology Consumption and Growth Rate (2017-2022)

    • Figure India Oncology Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oncology Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Oncology Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Oncology Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Oncology Consumption and Growth Rate (2017-2022)

    • Figure Thailand Oncology Consumption and Growth Rate (2017-2022)

    • Figure Singapore Oncology Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Oncology Consumption and Growth Rate (2017-2022)

    • Figure Philippines Oncology Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Oncology Consumption and Growth Rate (2017-2022)

    • Table South America Oncology Consumption by Country (2017-2022)

    • Figure Brazil Oncology Consumption and Growth Rate (2017-2022)

    • Figure Colombia Oncology Consumption and Growth Rate (2017-2022)

    • Figure Chile Oncology Consumption and Growth Rate (2017-2022)

    • Figure Argentina Oncology Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Oncology Consumption and Growth Rate (2017-2022)

    • Figure Peru Oncology Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Oncology Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Oncology Consumption and Growth Rate (2017-2022)

    • Table GCC Oncology Consumption by Country (2017-2022)

    • Figure Bahrain Oncology Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Oncology Consumption and Growth Rate (2017-2022)

    • Figure Oman Oncology Consumption and Growth Rate (2017-2022)

    • Figure Qatar Oncology Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Oncology Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Oncology Consumption and Growth Rate (2017-2022)

    • Table Africa Oncology Consumption by Country (2017-2022)

    • Figure Nigeria Oncology Consumption and Growth Rate (2017-2022)

    • Figure South Africa Oncology Consumption and Growth Rate (2017-2022)

    • Figure Egypt Oncology Consumption and Growth Rate (2017-2022)

    • Figure Algeria Oncology Consumption and Growth Rate (2017-2022)

    • Table Oceania Oncology Consumption by Country (2017-2022)

    • Figure Australia Oncology Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Oncology Consumption and Growth Rate (2017-2022)

    • Table Cepheid Company Details

    • Table Cepheid Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cepheid Oncology Main Business and Markets Served

    • Table Cepheid Oncology Product Portfolio

    • Table Beckton Dickinson Company Details

    • Table Beckton Dickinson Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckton Dickinson Oncology Main Business and Markets Served

    • Table Beckton Dickinson Oncology Product Portfolio

    • Table Roche Diagnostics Company Details

    • Table Roche Diagnostics Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics Oncology Main Business and Markets Served

    • Table Roche Diagnostics Oncology Product Portfolio

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Oncology Main Business and Markets Served

    • Table Abbott Laboratories Oncology Product Portfolio

    • Table Siemens Healthineers Company Details

    • Table Siemens Healthineers Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthineers Oncology Main Business and Markets Served

    • Table Siemens Healthineers Oncology Product Portfolio

    • Table Gen Probe Company Details

    • Table Gen Probe Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gen Probe Oncology Main Business and Markets Served

    • Table Gen Probe Oncology Product Portfolio

    • Table Danaher Corporation Company Details

    • Table Danaher Corporation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Corporation Oncology Main Business and Markets Served

    • Table Danaher Corporation Oncology Product Portfolio

    • Table Sysmex Corporation Company Details

    • Table Sysmex Corporation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sysmex Corporation Oncology Main Business and Markets Served

    • Table Sysmex Corporation Oncology Product Portfolio

    • Table Qiagen Company Details

    • Table Qiagen Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen Oncology Main Business and Markets Served

    • Table Qiagen Oncology Product Portfolio

    • Table Dako Company Details

    • Table Dako Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dako Oncology Main Business and Markets Served

    • Table Dako Oncology Product Portfolio

    • Table Bayer Healthcare Company Details

    • Table Bayer Healthcare Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Oncology Main Business and Markets Served

    • Table Bayer Healthcare Oncology Product Portfolio

    • Figure Global Instruments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Reagents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast by Country (2022-2028)

    • Table North America Oncology Consumption Forecast by Country (2022-2028)

    • Figure United States Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oncology Consumption Forecast by Country (2022-2028)

    • Figure Germany Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Oncology Consumption Forecast by Country (2022-2028)

    • Figure China Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Oncology Consumption Forecast by Country (2022-2028)

    • Figure Brazil Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Oncology Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Oncology Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Oncology Consumption Forecast by Country (2022-2028)

    • Figure Australia Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Oncology Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US